Page 4 - Thrombus News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Thrombus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Thrombus Today - Breaking & Trending Today
Further details from the phase 2b AZALEA trial of the factor XI inhibitor abelacimab show significant reductions in major and clinically relevant nonmajor bleeding vs rivaroxaban for patients with AF. ....
New wearable tech can predict menopausal vasomotor symptoms and initiate cooling in less than a second, potentially stopping the hot flash before it starts. ....
There were no significant safety signals in the younger pediatric population, and no treatment-emergent adverse events suggestive of systemic JAK inhibition, Dr Lawrence Eichenfield said. ....
There remains a knowledge gap regarding the risk of JAK inhibitor use and VTE and/or MACE in the dermatologic population, the study authors wrote. ....